Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Dipstick Assay Evaluated for Liver Fluke Diagnosis

By LabMedica International staff writers
Posted on 22 May 2012
A dipstick assay has been developed to diagnose fascioliasis, and its diagnostic efficacy evaluated in comparison to an immunoassay.

The dipstick uses excretory–secretory antigen from Fasciola gigantica dotted onto nitrocellulose paper using a sheet Mini-Protean II multiscreen apparatus to which human serum is applied. More...


Parasitologists at Ain Shams University (Cairo, Egypt) collected blood samples were collected from 60 individuals categorized into three groups. Group I consisted of 30 fascioliasis patients, diagnosed by detection of eggs of Fasciola in the stool and serologically by positive indirect hemagglutination test. Group II consisted of 20 patients with other parasitic diseases, and Group III consisted of 20 healthy individuals proven negative for fascioliasis and other parasitic diseases.

The enzyme linked immunosorbent assay (ELISA) was carried using a standard protocol and the absorbance was measured at 450 nm using a microplate reader. Samples were considered positive if their optical density was greater than the mean of healthy control samples plus three standard deviations. On the dipstick, a dark purple to brown band indicated a positive reaction.

The dipsticks' accuracy was 98.3%, with a sensitivity of 100%, a specificity of 96.7%, and negative predictive value of 100%. The sensitivity, specificity, and diagnostic accuracy of the ELISA were 100%, 96.7%, and 98.3%, respectively. The nitrocellulose paper and sheet Mini-Protean II multiscreen apparatus are both products of Bio-Rad (Hercules, CA, USA).

The authors concluded that the dipstick is a simple antigen and serum-conservative test requires only micrograms of parasite antigen and 20 µL of patient's sera. This test can be carried out while the patients wait, and would be more practical than what is currently done especially in rural areas and district hospitals. The test has its merit in being both qualitative, able to screen large numbers of blood samples, and quantitative assay, as the end-point titration of individual's sera can be determined. It is estimated that over 2.4 million people are infected with Fasciola species worldwide and around 91 million are at risk of infection. The study was published in the May 2012 issue of the journal Parasitology Research.

Related Links:
Ain Shams University
Bio-Rad



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.